- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07657000
Physical Activity in Bed Rest Hospitalized High-Risk Pregnant Women. (BedRest-1)
Physical Activity in Bed Rest Hospitalized High-Risk Pregnant Women
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
This study investigates the feasibility and potential benefits of a specifically designed exercise program for hospitalized high-risk pregnant individuals on bed rest. The program includes resistance and strength exercises tailored to be safely performed while in bed, aiming to counteract the physiological and psychological deconditioning associated with prolonged inactivity during hospitalization.
Prolonged bed rest during pregnancy, often prescribed for high-risk conditions, can result in muscle atrophy, reduced cardiovascular capacity, and psychological distress, including anxiety, stress, and depression. Despite the known adverse effects of inactivity, there is limited evidence on structured exercise programs for this population. This study seeks to fill that gap by testing an intervention designed to mitigate these negative outcomes.
Participants will be randomized into two groups: an exercise group (EG) and a no-exercise group (NEG). The EG will perform daily supervised exercises, lasting approximately 30 minutes, under the guidance of trained staff. The NEG will follow standard care without structured physical activity. The study evaluates physical health parameters (e.g., activity levels, muscle strength), mental health outcomes (e.g., anxiety, depression, stress), sleep quality, and quality of life. Secondary objectives include assessing program feasibility, recruitment rates, adherence, and participant satisfaction.
Data collection will include validated self-reported questionnaires, wearable devices (accelerometers), and clinical measures. Key endpoints will be compared between groups at regular intervals during hospitalization and at six weeks postpartum.
This pilot randomized controlled trial aims to generate knowledge on the acceptability, safety, and preliminary effectiveness of bed-rest exercise programs in high-risk pregnancies, with the goal of informing future larger-scale studies and addressing an unmet need in maternal care.
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Montse Palacio, MD, PhD
- Numéro de téléphone: 9946 +34932275400
- E-mail: secmmf@clinic.cat
Sauvegarde des contacts de l'étude
- Nom: Federico Migliorelli, Migliorelli, MD, PhD
- Numéro de téléphone: 9946 +34932275400
- E-mail: secmmf@clinic.cat
Lieux d'étude
-
-
Barcelona
-
Barcelona, Barcelona, Espagne, 08028
- Hospital Clinic de Barcelona
-
Contact:
- Montse Palacio, MD, PhD
- Numéro de téléphone: 9946 +34932275400
- E-mail: secmmf@clinic.cat
-
Contact:
- Federico Migliorelli, MD, PhD
- Numéro de téléphone: 9946 +34932275400
- E-mail: secmmf@clinic.cat
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
La description
Inclusion Criteria:
- Maternal age of 18 or more
- Delivery not expected within 1 week after recruitment.
- Language ability to understand the study.
- Informed consent signed.
Exclusion Criteria:
- Fetal death
- Severe mental health disorders and substance abuse disorders.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Soins de soutien
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Exercise group
Pregnant women admitted in the Maternal Intermediate Care Unit who will follow the standard management for its complication and will receiving the intervention and monitored according to study procedures
|
Programme d'exercices spécialement conçu et structuré (basé sur la résistance/force, conçu pour être exécuté au lit ou à mobilité minimale).
Il s'agit d'une adaptation du programme d'exercices décrit par Brun CR et al (Brun CR, Shoemaker JK, Bocking A, Hammond JA, Poole M, Mottola MF.
Exercice d'alitement, restriction d'activité et grossesses à haut risque : une étude de faisabilité.
Physiologie appliquée, nutrition et métabolisme.
2011;36(4):577-582).
|
|
Aucune intervention: Non-exercise group
Pregnant women admitted in the Maternal Intermediate Care Unit who will follow the standard management for its complication without any specific instructions to engage in physical activity, also monitored according to study procedures.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Évaluation de la faisabilité de la mise en œuvre du programme d'exercices : temps nécessaire pour recruter la taille de l'échantillon
Délai: À la fin des études, une moyenne de 6 mois
|
Temps nécessaire pour recruter la taille de l'échantillon (en jours)
|
À la fin des études, une moyenne de 6 mois
|
|
Évaluation de la faisabilité de la mise en œuvre du programme d'exercices : nombre de femmes qui ont refusé de participer à l'étude
Délai: À la fin des études, une moyenne de 6 mois
|
Nombre de femmes qui ont refusé de participer à l'étude
|
À la fin des études, une moyenne de 6 mois
|
|
Évaluation de la faisabilité de la mise en œuvre du programme d'exercices : nombre de femmes qui renoncent à participer à l'étude
Délai: À la fin des études, une moyenne de 6 mois
|
Nombre de femmes qui renoncent à participer à l'étude
|
À la fin des études, une moyenne de 6 mois
|
|
Évaluation de la faisabilité de la mise en œuvre du programme d'exercices : Adhésion au programme
Délai: À la fin des études, une moyenne de 6 mois
|
Adhésion au programme (nombre de jours d'exécution réelle du programme d'exercices pendant l'admission)
|
À la fin des études, une moyenne de 6 mois
|
|
Évaluation de la satisfaction
Délai: A la livraison
|
Un questionnaire réalisé spécifiquement pour le cas évaluant différents domaines (durée des séances, dureté des séances, répétition quotidienne des séances, difficulté d'exercices particuliers, volonté de redoubler en cas de réadmission, satisfaction globale d'être inclus dans le programme ) - Échelle de Likert (1 à 5, soit 1 pas du tout satisfait et 5 très satisfait).
|
A la livraison
|
|
Physiological parameters: Rectus femoris area measurement
Délai: Baseline, weeks 1, 2, 3, 4, 5 to 6 after enrolment, within 24h after delivery and 6 weeks postpartum
|
Loss of rectus femoris area (cm2) in a relaxed state, assessed by ultrasound
|
Baseline, weeks 1, 2, 3, 4, 5 to 6 after enrolment, within 24h after delivery and 6 weeks postpartum
|
|
Physiological parameters: Time spent in moderate or vigorous activity
Délai: Baseline, weeks 1, 2, 3, 4, 5 to 6 after enrolment, within 24h after delivery and 6 weeks postpartum
|
Time spent in moderate or vigorous activity (in minutes, summarized as average per day).
|
Baseline, weeks 1, 2, 3, 4, 5 to 6 after enrolment, within 24h after delivery and 6 weeks postpartum
|
|
Physiological parameters: Total physical activity
Délai: Baseline, weeks 1, 2, 3, 4, 5 to 6 after enrolment, within 24h after delivery and 6 weeks postpartum
|
Total physical activity (average per day in mG).
|
Baseline, weeks 1, 2, 3, 4, 5 to 6 after enrolment, within 24h after delivery and 6 weeks postpartum
|
|
Physiological parameters: Handgrip strength test.
Délai: Baseline, weeks 1, 2, 3, 4, 5 to 6 after enrolment, within 24h after delivery and 6 weeks postpartum
|
Handgrip strength test (in kg, adjusted for gender and age).
|
Baseline, weeks 1, 2, 3, 4, 5 to 6 after enrolment, within 24h after delivery and 6 weeks postpartum
|
|
Mental health/emotional parameters: GAD-7
Délai: Baseline, 2, 4 and 6 weeks after enrolment, whitin 24h after delivery and 6 weeks postpartum
|
GAD-7: Generalized Anxiety Disorder assessment scale (score ranging from 0 to 21).
The higher the results, higher is the severity of anxiety.
|
Baseline, 2, 4 and 6 weeks after enrolment, whitin 24h after delivery and 6 weeks postpartum
|
|
Mental health/emotional parameters: Perceived Stress Scale (PSS-10)
Délai: Baseline, 2, 4 and 6 weeks after enrolment, whitin 24h after delivery and 6 weeks postpartum
|
Perceived Stress Scale (PSS-10) (score ranging from 0 to 40).
The higher the results, higher is the perception of stress.
|
Baseline, 2, 4 and 6 weeks after enrolment, whitin 24h after delivery and 6 weeks postpartum
|
|
Mental health/emotional parameters: Edinburg Postpartum Depression Scale
Délai: Baseline, 2, 4 and 6 weeks after enrolment, whitin 24h after delivery and 6 weeks postpartum
|
Edinburg Postpartum Depression Scale (EPDS) (score -ranging from 0 to 30- and percentage of score ≥9).
The higher the total score, more intense is the emotional stress.
|
Baseline, 2, 4 and 6 weeks after enrolment, whitin 24h after delivery and 6 weeks postpartum
|
|
Sleep cycle and Quality of life parameters: Sleep average per night
Délai: Baseline, 2, 4 and 6 weeks after enrolment, whitin 24h after delivery
|
Sleep average per night (in minutes)
|
Baseline, 2, 4 and 6 weeks after enrolment, whitin 24h after delivery
|
|
Sleep cycle and Quality of life parameters: WHOQOL-BREF score
Délai: Baseline, 2, 4 and 6 weeks after enrolment, whitin 24h after delivery
|
Abbreviated version of the World Health Organization Quality of Life Assessment scale (WHOQOL-BREF) (score ranging from 0 to 100).
The higher the score, better is the perception of quality of life.
|
Baseline, 2, 4 and 6 weeks after enrolment, whitin 24h after delivery
|
|
Mental health/emotional parameters: SAM: The Self-Assessment Manikin
Délai: Daily
|
Visual standardized measure of emotional tone that covers 3 different affective domains (valence, arousal and sense of control).
Responses are made by selecting the manikin that best represents the emotional state of the patient.
The patient selection is afterwards converted into a numerical result with higher scores indicating more positive affective tone.
|
Daily
|
|
Mental health/emotional parameters: RRS: The Ruminative Response Scale
Délai: Baseline, 2, 4 and 6 weeks after enrolment, whitin 24h after delivery and 6 weeks postpartum
|
10-item questionnaire intended to measure rumination, tendency to worriedness and repetitive thinking in front of stressful situations.
(score ranking from 10 to 40).
Higher scores indicate a higher tendeny to ruminate and a vulnerability trait to psychological distress
|
Baseline, 2, 4 and 6 weeks after enrolment, whitin 24h after delivery and 6 weeks postpartum
|
|
Mental health/emotional parameters: BDI-II:
Délai: Baseline, 2, 4 and 6 weeks after enrolment, whitin 24h after delivery and 6 weeks postpartum
|
Questionnaire to measuring depression at a cognitive, affective and behavioral level.
For the present study only 4 items related to hedonic experience will be selected.
Higher scores in each item indicate severity in the loss of hedonic capacity.
Reponses are made by using a 4-point Likert scale.
|
Baseline, 2, 4 and 6 weeks after enrolment, whitin 24h after delivery and 6 weeks postpartum
|
|
Physiological parameters: Muscle Ultrasound
Délai: Baseline, 2, 4 and 6 weeks after enrolment, whitin 24h after delivery and 6 weeks postpartum
|
Muscle ultrasound will be conducted weekly by blinded sonographers using a linear probe (7.5 - 10 MHz).
All images will be acquired in triplicate, and the average value will be used for analysis.
|
Baseline, 2, 4 and 6 weeks after enrolment, whitin 24h after delivery and 6 weeks postpartum
|
|
Physiological parameters: Maternal Cardiac Ultrasound
Délai: Baseline, 2, 4 and 6 weeks after enrolment, whitin 24h after delivery and 6 weeks postpartum
|
Transthoracic echocardiography will be performed using standardised imaging protocols.
All measurements will be performed in triplicate when feasible, and averaged for analysis.
Standardization of acquisition settings and operator blinding to clinical data will be ensured to reduce measurement bias.
|
Baseline, 2, 4 and 6 weeks after enrolment, whitin 24h after delivery and 6 weeks postpartum
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Baseline Maternal and fetal characteristics: Evaluation of physical activity (GAQ-P questionnaire)
Délai: Baseline
|
The questionnarie self-clasisfies how often and for how long the participant engages in light-, moderate-, or vigorous-intensity physical activity.
It also assesses whether the participant should consult her obstetric health care provider before beginning or continuing physical activity during pregnancy.
The GAQP is a screening and classification tool and does not generate a numerical summary score.
Therefore, no minimun or maximum applies, and higher or lower scores do not indicate a better or worse outcome.
|
Baseline
|
|
Baseline Maternal and fetal characteristics: Maternal age
Délai: Baseline
|
Maternal age (In years)
|
Baseline
|
|
Baseline Maternal and fetal characteristics: Maternal weight
Délai: Baseline
|
Maternal weight (In kg)
|
Baseline
|
|
Baseline Maternal and fetal characteristics: Ethnic group
Délai: Baseline
|
Ethnic group classified as: - White/European - Hispanic/latin American - Black/African Americans - Arabic - Asian
|
Baseline
|
|
Baseline Maternal and fetal characteristics: Gestational age at recruitment
Délai: Baseline
|
Gestational age at recruitment (in weeks + days)
|
Baseline
|
|
Baseline Maternal and fetal characteristics: Twin pregnancy
Délai: Baseline
|
Twin pregnancy (yes/no)
|
Baseline
|
|
Baseline Maternal and fetal characteristics: Fetal growth percentile at admission
Délai: Baseline
|
Fetal growth percentile at admission (customized for gender and multiplicity)
|
Baseline
|
|
Baseline Maternal and fetal characteristics: Medical condition that justifies hospital admission
Délai: Baseline
|
Medical condition that justifies hospital admission (hypertensive disorders, preterm labor, rupture of membranes, antepartum bleeding, others)
|
Baseline
|
|
Baseline Maternal and fetal characteristics: Musculoskeletal limitations
Délai: Baseline
|
Musculoskeletal limitations (injuries or pathologies) (yes/no and description)
|
Baseline
|
|
Maternal and fetal characteristics during hospital admission: Medication while admitted
Délai: Baseline, 1, 2, 3, 4, 5 and 6 weeks after enrolment, whitin 24h after delivery and 6 weeks postpartum
|
Medication while admitted (antihypertensive treatment, tocolysis, magnesium sulphate, antibiotics, corticosteroids, others)
|
Baseline, 1, 2, 3, 4, 5 and 6 weeks after enrolment, whitin 24h after delivery and 6 weeks postpartum
|
|
Maternal and fetal characteristics during hospital admission: Length of stay in the intermediate care unit
Délai: Baseline, 1, 2, 3, 4, 5 and 6 weeks after enrolment, whitin 24h after delivery and 6 weeks postpartum
|
Length of stay in the intermediate care unit (in days)
|
Baseline, 1, 2, 3, 4, 5 and 6 weeks after enrolment, whitin 24h after delivery and 6 weeks postpartum
|
|
Maternal and fetal characteristics during hospital admission: Length of hospital admission
Délai: Baseline, 1, 2, 3, 4, 5 and 6 weeks after enrolment, whitin 24h after delivery and 6 weeks postpartum
|
Length of hospital admission (in days)
|
Baseline, 1, 2, 3, 4, 5 and 6 weeks after enrolment, whitin 24h after delivery and 6 weeks postpartum
|
|
Maternal and fetal characteristics during hospital admission: Fetal CTG
Délai: Baseline, 1, 2, 3, 4, 5 and 6 weeks after enrolment, whitin 24h after delivery and 6 weeks postpartum
|
Fetal CTG description
|
Baseline, 1, 2, 3, 4, 5 and 6 weeks after enrolment, whitin 24h after delivery and 6 weeks postpartum
|
|
Maternal and fetal characteristics during hospital admission: Diet during the admission
Délai: Baseline, 1, 2, 3, 4, 5 and 6 weeks after enrolment, whitin 24h after delivery and 6 weeks postpartum
|
Diet during the admission (in Kcal and special needs)
|
Baseline, 1, 2, 3, 4, 5 and 6 weeks after enrolment, whitin 24h after delivery and 6 weeks postpartum
|
|
Maternal and fetal characteristics during hospital admission: Daily fluid intake
Délai: Baseline, 1, 2, 3, 4, 5 and 6 weeks after enrolment, whitin 24h after delivery and 6 weeks postpartum
|
Daily fluid intake (in mL)
|
Baseline, 1, 2, 3, 4, 5 and 6 weeks after enrolment, whitin 24h after delivery and 6 weeks postpartum
|
|
Perinatal outcomes: Gestational age at delivery
Délai: Whitin 24h after delivery and 6 weeks postpartum
|
Gestational age at delivery (in weeks + days
|
Whitin 24h after delivery and 6 weeks postpartum
|
|
Perinatal outcomes: Birthweight
Délai: Whitin 24h after delivery and 6 weeks postpartum
|
Birthweight (in grams) and percentile
|
Whitin 24h after delivery and 6 weeks postpartum
|
|
Perinatal outcomes: SGA/growth restriction
Délai: Whitin 24h after delivery and 6 weeks postpartum
|
SGA/growth restriction (yes/no) and classification, if any
|
Whitin 24h after delivery and 6 weeks postpartum
|
|
Perinatal outcomes: Mode of delivery
Délai: Whitin 24h after delivery and 6 weeks postpartum
|
Mode of delivery (spontaneous, assisted, cesarean section)
|
Whitin 24h after delivery and 6 weeks postpartum
|
|
Perinatal outcomes: Composite adverse maternal outcome
Délai: Whitin 24h after delivery and 6 weeks postpartum
|
Composite adverse maternal outcome (yes/no considering any of the following: re-intervention, endometritis, infection of surgical wound, curettage, admission to intensive care unit, hysterectomy, need for transfusion, postpartum hemorrhage requiring medication other than oxytocin or ergometrine, maternal sepsis, death)
|
Whitin 24h after delivery and 6 weeks postpartum
|
|
Perinatal outcomes: Neonatal admission to neonatal intensive care unit
Délai: Whitin 24h after delivery and 6 weeks postpartum
|
Neonatal admission to neonatal intensive care unit (yes/no)
|
Whitin 24h after delivery and 6 weeks postpartum
|
|
Perinatal outcomes: Composite adverse neonatal outcome
Délai: Whitin 24h after delivery and 6 weeks postpartum
|
Composite adverse neonatal outcome: (yes/no considering any of the following: respiratory morbidity - respiratory distress syndrome or transient tachypnea - requiring intubation, moderate-severe bronchopulmonary dysplasia, intraventricular hemorrhage grade III-IV, early-onset sepsis, periventricular leukomalacia, necrotizing enterocolitis, retinopathy requiring laser, fetal or neonatal death)
|
Whitin 24h after delivery and 6 weeks postpartum
|
|
Perinatal outcomes: Breastfeeding rates
Délai: Whitin 24h after delivery and 6 weeks postpartum
|
Breastfeeding rates
|
Whitin 24h after delivery and 6 weeks postpartum
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Federico Migliorelli, MD, PhD, Gynecologist especialist on Maternal fetal medicine
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- BedRest Pregnancy Study
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .